Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 2021

View Archived Issues

Bio-Thera Solutions initiates phase I study of BAT-1308 in advanced solid tumors

Target enrollment complete in diabetic foot ulcer study of SkinTE

EuBiologics receives IND approval in Korea for its COVID-19 vaccine candidate

FDA clears IND for phase II study of LTX-315

U.S. IND application cleared for UX-701 gene therapy for Wilson disease

Codiak Biosciences describes extracellular vesicles targeting T cells

Cell therapy targeting BCL11A gene safely induces erythrocyte fetal hemoglobin

Lyndra initiates phase I study of its rosuvastatin extended-release capsule

First participants dosed in phase II study of MV-012-968

Tau end run prevents memory deficits, but not inflammation

SCLC subtypes have specific vulnerabilities

Sunshine Lake Pharma discovers ACC1/ACC2 inhibitors

INmune Bio reports biomarker data from phase Ib study of XPro-1595 in Alzheimer's

Addition of tocilizumab does not improve clinical outcome in severe or critical COVID-19

New STING modulators identified at Camphor Pharmaceuticals

New chymase inhibitors patented by Medshine Discovery

SC-75741 potently inhibits the replication of bandaviruses in vitro

Phase II trial of SURF-201 for post-cataract surgery pain and inflammation meets endpoints

UCB describes new dopamine D1 receptor PAMs

FDA approves Cabenuva long-acting regimen for HIV-1 infection in adults

Oramed begins randomization in phase III study of oral insulin capsule ORMD-0801

ARB-202: a bispecific MAb useful against CDH17-positive GI cancers

SFX-01 shrinks tumors and extends survival in preclinical models of glioma and glioblastoma

Sutro begins ovarian cancer dose-expansion cohort in phase I study of STRO-002

Phase III data show bamlanivimab reduces risk of symptomatic COVID-19 in nursing homes

Partial clinical hold lifted on phase I studies of PRS-343

Adlumiz approved in Japan for cancer cachexia

European Commission approves Elzonris for blastic plasmacytoid dendritic cell neoplasm

GSK discontinues phase II trial of GSK-2831781 in ulcerative colitis

Aging immune cell energy "hoarders" play role in brain decline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.